A Single Microfocus (5% or Less) of Gleason 6 Prostate Cancer at Biopsy-Can We Predict Adverse Pathological Outcomes?

Journal of Urology

Volumn 180, Issue 6, 2008, Pages 2436-2440

  Thong, Alan E ^a   Shikanov, Sergey ^a   Katz, Mark H ^a   Gofrit, Ofer N ^a   Eggener, Scott ^a   Zagaja, Gregory P ^a   Shalhav, Arieh L ^a   Zorn, Kevin C ^a  

^a UNIVERSITY OF CHICAGO MEDICAL CENTER   (United States)

Author keywords

biopsy; prognosis; prostate; prostatectomy; prostatic neoplasms

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; GLEASON SCORE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; NEEDLE BIOPSY; ORGAN SIZE; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; PROGNOSIS; PROSTATE CANCER; PROSTATECTOMY; RISK FACTOR; TUMOR BIOPSY;

ADULT; AGED; BIOPSY, NEEDLE; HUMANS; MALE; MIDDLE AGED; NEOPLASM STAGING; PREDICTIVE VALUE OF TESTS; PROSTATECTOMY; PROSTATIC NEOPLASMS; TREATMENT OUTCOME;

EID: 55549140122     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.juro.2008.08.027     Document Type: Article

References (17)

1. Catalona W., Smith D., Ratliff T., and Basler J. Detection of organ-confined prostate cancer is increased through prostate-specific antigen-based screening. JAMA 270 (1993) 948
2. Cooperberg M.R., Broering J.M., Litwin M.S., Lubeck D.P., Methta S.S., Henning J.M., et al. The contemporary management of prostate cancer in the United States: lesions from the Cancer of the Prostate Strategic Urologic Research Endeavor (CaPSURE), a national disease registry. J Urol 171 (2004) 1393
3. D'Amico A.V., Wu Y., Chen M., Nash M., Renshaw A.A., and Richie J.P. Pathologic findings and prostate specific antigen outcome after radical prostatectomy for patients diagnosed on the basis of a single microscopic focus of prostate carcinoma with a Gleason score ≤7. Cancer 89 (2000) 1810
4. Cupp M.R., Bostwick D.G., Myers R.P., and Oesterling J.E. The volume of prostate cancer in the biopsy specimen cannot reliably predict the quantity of cancer in the radical prostatectomy specimen on an individual basis. J Urol 153 (1995) 1543
5. Lee A.K., Doytchinova T., Chen M., Renshaw A.A., Weinstein M., Richie J.P., and D'Amico A.V. Can the core length involved with prostate cancer identify clinically insignificant disease in low risk patients diagnosed on the basis of a single positive core?. Urol Oncol 21 (2003) 123
6. Thorson P., Vollmer R.T., Arcangeli C., Keetch D.W., and Humphrey P.A. Minimal carcinoma in prostate needle biopsy specimens: diagnostic features and radical prostatectomy follow-up. Mod Pathol 11 (1998) 543
7. Terris M.K., and Stamey T.A. Determination of prostate volume by transrectal ultrasound. J Urol 145 (1991) 984
8. Wolff J.M., Boeckmann W., Mattelaer P., Handt S., Adam G., and Jakse G. Determination of prostate gland volume by transrectal ultrasound: correlation with radical prostatectomy specimens. Eur Urol 28 (1995) 10
9. Zorn K.C., Gofrit O.N., Orvieto M.A., Mikhail A.A., Zagaja G.P., and Shalhav A.L. Robotic-assisted laparoscopic prostatectomy: functional and pathologic outcomes with interfascial nerve preservation. Eur Urol 51 (2007) 755
10. Menon M., Tewari A., Peabody J.O., Shrivastava A., Kaul S., Bhandari A., and Hemal A.K. Vattikuti Institute prostatectomy, a technique of robotic radical prostatectomy for management of localized carcinoma of the prostate: experience of over 1100 cases. Urol Clin North Am 31 (2004) 701
11. Amin M.B., Grignon D., Bostwick D., Reuter V., Troncoso P., and Ayala A.G. Recommendations for the reporting of resected prostate carcinomas. Association of Directors of Anatomic and Surgical Pathology. Am J Clin Pathol 105 (1996) 667
12. Greene F.L., Page D.L., Fleming I.D., Fritz A., Balch C.M., Haller D.G., et al. Prostate. AJCC Cancer Staging Manual. 6th ed. (2002), Springer Publishing, New York part IX, chapt 34, p 3098
13. Allan R.W., Sanderson H., and Epstein J.I. Correlation of minute (0.5mm or less) focus of prostate adenocarcinoma on needle biopsy with radical prostatectomy specimen: role of prostate specific antigen density. J Urol 170 (2003) 270
14. Wills M.L., Sauvageot J., Partin A.W., Gurganus R., and Epstein J.I. Ability of sextant biopsies to predict radical prostatectomy stage. Urology 51 (1998) 759
15. Keetch D.W., Catalona J., and Smith D.S. Serial prostatic biopsies in men with persistently elevated serum prostate specific antigen values. J Urol 151 (1994) 1571
16. Sheridan T.B., Carter H.B., Wang W., Landis P.B., and Epstein J.I. Change in prostate cancer grade over time in men followed expectantly for stage T1c disease. J Urol 179 (2008) 901
17. Boccon-Gibod L.M., Dumonceau O., Toublanc M., Ravery V., and Boccon-Gibod L.A. Micro-focal prostate cancer: a comparison of biopsy and radical prostatectomy specimen features. Eur Urol 48 (2005) 895